Browsing by Autor "Gianella, A"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item type: Item , [Epidemic outbreak of dengue virus 2/Jamaica genotype in Bolivia].(1998) Gianella, A; Pirard, M; Holzman, A; Boelaert, M; Fernández-Ortiz, F; Peredo, C; Pelegrino, J L; Van der Stuyft, POBJECTIVE: To confirm an epidemic outbreak of Dengue virus in the city of Santa Cruz, Bolivia, and to determine the serotype of the virus, to estimate the rate of attack and the proportion of symptomatic infections. MATERIAL AND METHODS: In March 1997, a seroepidemiological survey was conducted with random sampling in a central district of the city of Santa Cruz, Bolivia. Information on recent acute illness and febrile episodes was gathered, and venous blood samples were obtained. Levels of antidengue IgM were determined by MAC Elisa and the virus was typified with RT-PCR. RESULTS: IgM antibodies were detected in 6.5% of adults (CI 95% 3.4-9.6) and 5.1% of children (CI 95% 2.0-8.2). Circulating virus was identified as Dengue serotype 2, subgroup Jamaica. Less than half of the infected children experienced a symptomatic infection compared to almost 90% of adults. CONCLUSIONS: The estimated attack rates are compatible with a Dengue epidemic outbreak in Santa Cruz. The introduction of the serotype 2/ subgroup Jamaica virus into the country increases the risk of hemorrhagic Dengue.Item type: Item , Epidemiological analysis of the influenza A(H1N1)v outbreak in Bolivia, May-August 2009.(2009) Gianella, A; Walter, A; Revollo, R; Loayza, R; Vargas, J; Roca, YThe outbreak of pandemic influenza (H1N1) began in Bolivia on 25 May 2009. Between May and August, the National Center of Tropical Disease (CENETROP) analysed by RT-PCR 7,060 samples of which 12.7% were positive. A preliminary analysis of the 895 confirmed cases identified between May and August 2009 describes epidemiological and clinical characteristics. After the first imported cases from the United States and Peru, the locally acquired infections predominated (90%). The number of cases was highest in the age group of 10 to 29 year-olds, and 89.6% of cases were observed in people under the age of 40 years. Fever, cough, nasal discharge and headache remained the main symptoms.